Aiolos Bio has raised $245M in total funding. Latest round: Series A. Backed by Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners.
Aiolos Bio funding overview
Aiolos Bio has raised $245M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2023. The round record for Aiolos Bio runs through 2023; nothing later has been disclosed. Investors on record include Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments, RA Capital Management. 5 distinct backers are named across the disclosed rounds.
Aiolos Bio at a glance
Total raised
$245M
Latest round
Series A
Latest round date
October 2023
Notable investors
Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments, RA Capital Management
Frequently asked about Aiolos Bio funding
How much has Aiolos Bio raised?
Aiolos Bio has raised $245M in total disclosed funding across the rounds on record.
Who has invested in Aiolos Bio?
Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments, RA Capital Management are named among the investors backing Aiolos Bio.
What was the latest Aiolos Bio funding round?
The most recent disclosed round is a Series A, announced in October 2023.
Where is Aiolos Bio based?
No headquarters location is disclosed for Aiolos Bio.
When did Aiolos Bio last raise?
The last disclosed Aiolos Bio round closed in October 2023 at Series A.
Totals shown for Aiolos Bio aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
